Article Versions Notes

Kattenhøj KD, Møberg CL, Guldbrandt LM, Friis RB, Mapendano CK, Petersen SK, Ruhlmann CHB, Svane IM, Donia M, Ellebaek E, et al. Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases—A Danish Real-World Cohort. Cancers. 2024; 16(14):2559. https://doi.org/10.3390/cancers16142559

Kattenhøj, Karoline Dreyer, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, and et al. 2024. "Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases—A Danish Real-World Cohort" Cancers 16, no. 14: 2559. https://doi.org/10.3390/cancers16142559

Kattenhøj, K. D., Møberg, C. L., Guldbrandt, L. M., Friis, R. B., Mapendano, C. K., Petersen, S. K., Ruhlmann, C. H. B., Svane, I. M., Donia, M., Ellebaek, E., & Schmidt, H. (2024). Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases—A Danish Real-World Cohort. Cancers, 16(14), 2559. https://doi.org/10.3390/cancers16142559